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Identity 
Other names: FRE, FRITZ, FRP-3, FRP, FRZB-1, 
FRZB-PEN, FRZB1, FZRB, OS1, SFRP3, hFIZ 




Genomic size: 40762 bp, encoded by 6 exons. 
Transcription 
Transcript length: 3162 bp; mRNA: 978 bp. 
Pseudogene 
Human FRZB has only 1 known transcript. 
Protein 
Description 
FRZB protein is comprised of 325 amino acids with  
a molecular weight of 36 kDa. FRZB is a member of 
the secreted frizzled related protein (SFRP) family, of 
which five members (SFRP1 to SFRP5) are known 
within the human genome. SFRPs fold into two 
independent domains, the cysteine-rich domain (CRD) 
and the Netrin-like domain (NTN). The CRD domain 
shares sequence homology with the extracellular 
portion of the WNT receptor Frizzled (Fz).  
Therefore, the CRD domain is considered the WNT 
binding domain.  
The NTN domain contains six cysteine residues that 
most likely form three disulfide bridges and NTN 
domains with similar features are found in several 
unrelated proteins, including Netrin-1, tissue inhibitors 
of metallo-proteinases (TIMPs), complement proteins 
and type I procollagen C-proteinase enhancer proteins 
(PCOLCEs).  
The overall function of the NTN domain is unknown. 
However, one study demonstrated that both domains 
are necessary for optimal WNT inhibition (Jones et al., 
2002; Bath et al., 2007). 
 
The FRZB gene (40762 bp) contains a total of 6 exons and the FRZB transcript is 978 bp. 
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Structure of FRZB. FRZB contains a cysteine-rich domain (CRD) and a Netrin-like (NTN) domain. It is hypothesised that the 
antagonistic effects of FRZB can be explained by the binding of WNTs to the CRD domain. 
 
Expression 
SFRP3 (FRZB) was originally isolated from bovine 
articular cartilage. During human embryonic and fetal 
development FRZB is primarily expressed in 
cartilaginous cores of developing long bones (Hoang et 
al., 1996). In the early mouse embryo, mFrzb-1 is 
expressed in the primitive streak, presomitic mesodrm, 
somites, and brain. Later, mFrzb-1 exhibits sharp 
boundaries of expression in the limb bud, branchial 
arches, facial mesenchyme, and in cartilaginous 
elements of the appendicular skeleton (Hoang et al., 
1998). 
Localisation 
Extracellular space, bound to plasma membrane. 
Function 
FRZB is involved in the WNT/beta-catenin signalling 
pathway by acting as an inhibitor by binding to WNT 
ligands. However, recent studies indicate that SFRPs 
can modulate WNT signalling and are able to interact 
with molecules that are unrelated to the WNT 
signalling cascades and among which there is no 
apparent relationship (Bovolenta et al., 2008). 
Homology 
FRZB is a member of the secreted frizzled related 
protein (SFRP) family (SFRP1-5). Based on their 
amino acid sequence homology, they are divided into a 
subgroup consisting of SFRP1, SFRP2 and SFRP5 and 
a subgroup comprising SFRP3 (FRZB) and SFRP4. 
SFRPs contain a CRD domain that shares sequence 
homology with the extracellular portion of the WNT 
receptor Frizzled (Fz) (Jones et al., 2005). 
Mutations 
Germinal 
The only clinically associated variants of FRZB are 
Arg200Trp (exon 4) and Arg324Gly (exon 6). Both of 
them are substitutions for a conserved arginine residu . 
One or two FRZB SNPs or a haplotype containing both 
were found to be associated to knee, hip, generalizd 
and radiographic osteoarthritis (Loughlin et al., 2004; 
Min et al., 2005; Lories et al., 2005; Lane et al.,2006; 
Valdes et al., 2007). However, the results from a recent 
meta-analysis showing no overall effect of FRZB 
genetic variants on hip or knee OA debated this 




Osteoarthritis is a chronic degenerative joint disease 
without underlying autoimmune or autoinflammatory 
mechanisms. The disease leads to pain and disability 
and affects millions of people worldwide. Although 
once considered as a disease of the articular cartilage, 
the current concept holds that the whole joint is 
involved, including the subchondral bone, menisci, 
ligaments, periarticular muscle, capsule and synovium. 
Osteoarthritis is a complex disorder to which both 
genetic and acquired factors contribute (Hunter et al., 
2006).  
Polymorphisms in FRZB (Arg200Trp and Arg324Gly) 
have been associated with osteoarthritis (Loughlin et 
al., 2004; Min et al., 2005; Lories et al., 2005; Lane et 
al., 2006; Valdes et al., 2007).  
However, the results from a recent meta-analysis 
showing no overall effect of FRZB genetic variants on 
hip or knee OA debated this association (Evangelou t 
al., 2009).  
Recently, a transcriptomics analysis in Frzb-/- mice 
provided evidence for a tight regulation of WNT 
signalling and highlighted the complex role for FRZB 
in joint homeostasis (Lodewyckx et al., 2012). 
Moreover, Frzb-/- mice show increased cartilage 
damage when challenged by different models of acute 
and short-term joint, suggesting a role for FRZB in 
osteoarthritis. The observed cartilage damage was 
associated with increased WNT signalling and matrix 
metalloproteinase 3 (MMP-3) expression and activity. 
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Additionally, Frzb-/- mice have increased cortical bone 
thickness and density without changes in the trabecular 
bone (Lories et al., 2007). 
Cytogenetics 
The haplotype coding for substitutions of two highly 
conserved arginine residues (Arg200Trp and 
Arg324Gly) in FRZB are associated with hip 
osteoarthritis in females. Moreover, transfection studies 
indicated that substitutions of these positively charged 
residues reduced the ability of FRZB to inhibit WNT 
signalling (Loughlin et al., 2004). Additionally, an 
association analysis confirmed that the R324G variant 
of the FRZB gene is involved in osteoarthritis and 
indicates a role of this variant in several generalized 
OA phenotypes (Min et al., 2005). Next, evidence was 
found for a differential association of the FRZB 
Arg200Trp polymorphism with hip osteoarthritis and 
osteoporosis (Lories et al., 2005). Lane et al. confirmed 
the earlier finding that a rare haplotype with both 
Arg200Trp and Arg324Gly FRZB variants contributes 
to hip osteoarthritis in women. Further, an association 
of genetic polymorphisms of FRZB and knee 
osteoarthritis was found (Valdes et al., 2007). In 
contrast, Rodriguez-Lopez et al. could not find an 
association of FRZB polymorphisms with either 
generalised osteoarthritis or hip OA. But, their results 
suggest that the Arg324Gly SNP may have an effect in 
the development of osteoarthritis in multiple joints. 
Furthermore, a large-scale meta-analysis of individual-
level data does not support the association of SNPs of 
FRZB with osteoarthritis (Evangelou et al., 2009). 
Colorectal cancer 
Note 
The functional genetic variant Arg324Gly of FRZB 
was shown to be associated with colorectal cancer risk 
(Shanmugam et al., 2007). However, Berndt et al. 
observed no association for either polymorphisms 
(Arg324Gly and Arg200Trp) or any haplotypes with 
colorectal adenoma or colorectal cancer. 
Gastric cancer 
Note 
Overexpression of FRZB in gastric cancer cell 
suppresses proliferation and modulates the balance 
between proliferation and differentiation in gastric 
cancer (Qu et al., 2008c). Additionally, FRZB exhibits 
anti-tumor ability in gastric cancer cell line SGC-7901 
in vitro and in vivo, and decreases the expression of 
MMP-2, MMP-7 and MMP-9 leading to a reduced 
invasion ability of the tumor cells (Qu et al., 2008b). 
Prostate cancer 
Note 
Ectopic expression of FRZB in an androgen-
independent prostate cancer cellular model results in 
the suppression of tumor growth and cellular 
invasiveness. This provides evidence that FRZB can a t 
as a tumor suppressor gene (Zi et al., 2005). 
Osteogenic sarcoma 
Note 
Micro-array analysis shows that FRZB has virtually no 
mRNA expression in osteogenic sarcoma-derived 
specimens compared to control (Mandal et al., 2007). 
Breast cancer 
Note 
Expression of FRZB is turned off in breast carcinomas 
(versus normal breasts). These results suggest that 




A kidney tissue microarray and analysis of FRZB 
overexpression in a renal cancer cell line shows that
sFRP3 expression promotes cell growth, invasion, and 




Methylation of HOXB2, KRT13 and FRZB are 
associated with aggressive invasive bladder cancer 
(Marsit et al., 2010). 
Malignant pleural mesothelioma 
Note 
The transcription of the SFRP family is frequently 
down-regulated in human malignant pleural 
mesothelioma (Lee et al., 2004). 
Soft tissue sarcomas 
Note 
FRZB overexpression in fibrosarcoma and liposarcoma 
cell lines reduces cell motility, invasiveness and 
tumorigenesis.  
These results implicate an important tumor suppressiv  
function for FRZB in sarcomas (Guo et al., 2008). 
Melanoma 
Note 
FRZB expression is reduced in malignant melanoma 
tissues and cell lines compared to normal cells and this 
down-regulation is related to methylation of the FRZB 
gene.  
Additionally, recombinant FRZB decreases migration 
and invasion of melanoma cells (Ekström et al., 2011). 
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